June 30, 2025- Roche announced that Johannes (Hans) Clevers (1957), M.D., Ph.D., Head of Roche Pharma Research and Early Development (pRED) and member of the enlarged Corporate Executive Committee will be retiring from Roche. Hans Clevers joined the Roche Board of Directors in 2019 and then was appointed Head of Roche pRED in March 2022. Also, Barbara Schädler (1962), Head of Group Communications and member of Roche’s enlarged Corporate Executive Committee, will retire from the company at the end of the year. Barbara Schädler joined Roche in 2019. Roche states that the company will announce the successors in due course.